Trial Profile
Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T using gadobenate dimeglumine in patients with chronic myocardial infarction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Gadobenic acid (Primary)
- Indications Myocardial infarction
- Focus Diagnostic use
- 03 Nov 2015 New trial record